Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q2- Text added to 2020 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman V good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman V good
|
New words:
Alexander, amyotrophic, angioedema, ataxin, cancellation, cancelled, Cardiology, cohort, cystic, document, dyslipidemia, EPS, evolution, fitusiran, flat, gene, Genuity, greatest, harmonizing, hypertriglyceridemia, incompatibility, inhaled, intrathecal, Lafora, largest, led, legacy, LLC, meaningful, pelacarsen, PKK, pool, rejoin, retention, Sanofi, simplifying, SRLY, stronger, structure, thalassemia, thereunder, turnover, volunteer, wide
Valuein 2020 Q2 filing- Value in 2020 Q3 filing
Original filings
Filing view